Introduction
The two most important questions to ask about polio eradication are 'why?' and 'how?'. This article briefly sets out the answers to these questions, explaining both the rationale and operational feasibility of polio eradication. We also outline the progress toward global eradication and the central role that clinicians and district and regional medical officers play in ensuring its ultimate success.
The polio eradication initiative
The Global Polio Eradication Initiative (PEl) was launched by the World Health Assembly (WHA) in 1988 and adopted at the World Summit for Children in 1990. Spearheaded by the World Health Organization (WHO), Rotary International, the Centers for Disease Control and Prevention and UNICEF, the PEl has united in a common goal Ministries of Health from developing and industrialized countries, donor governments, technical agencies, research institutions and the private sector.
The ultimate aim of the eradication mrtiative is not simply the interruption of wild poliovirus transmission globally, but the much larger goal of improving global capacity to control other major causes of childhood morbidity and mortality'. The PEl has been in many ways a trailblazer for other international health partnerships, demonstrating the benefits of partnership in establishing common purposes and methods of working towards clearly defined targets.
How and why to eradicate polio?
While it was sufficient to justify an assault on Mount Everest with the famous reason 'because it is there', public health officials need a much broader base from which to launch an eradication assault on a specific disease. First, it must be technically and operationally feasible to move from control to eradication and secondly, there must be sound cost-benefit arguments for doing so. Finally, there must be the societal and political support necessary to launch and sustain an eradication initiative over a prolonged period of time. 246 
Feasibility of polio eradication Technical feasibility
It is possible to eradicate polio because it fulfils the three criteria of primary importance in determining the technical feasibility of eradicating a particular organisrrr':
• there is an effective intervention that can interrupt transmission (oral polio vaccine) • practical diagnostic tools exist with sufficient sensitivity and specificity to detect levels of infection that can lead to transmission (culture of stool specimens) • humans are essential for the life cycle of the organism, which has no other vertebrate reservoir and does not amplify in the environment.
Operational feasibility
Critical to the success of an eradication initiative is translating the technical feasibility into simple strategies which can be effectively applied virtually anywhere in the world. The four WHO-recommended strategies for interrupting wild poliovirus transmission have proven very robust. They are: high routine immunization coverage l > 80% with OPV3 (oral poliovirus vaccine)];
National Immunization Days (NIDs); surveillance and laboratory investigation of all cases of acute flaccid paralysis (AFP) among children aged less than 15 years; and massive house-to-house mop-up activities to interrupt the final chains of transmission 3 . NIDs have become the mainstay of the polio eradication initiative in endemic countries as they rapidly interrupt transmission by boosting both systemic and intestinal immunity. The simultaneous feeding of OPV to the largest possible number of children in a very short time period 'floods' the community with the vaccine virus, dramatically reducing the possibility of the wild poliovirus finding a susceptible host and sustaining itself. Thus NIDs not only boost individual immunity but also break the chains of wild poliovirus circulation.
When the Global PEl was launched in 1988, the operational feasibility of the strategies had been clearly demonstrated in the WHO Region of the Americas. Since then the strategies have been implemented under virtually every condition imaginable, regardless of geography, climate, culture, civil strife or war. For example, NIDs have been successfully implemented in countries ranging from Afghanistan to Somalia and the Democratic Republic of the Congo", As of 1999, there is no population pocket on earth of the size necessary (i.e. greater than I million susceptibles) to maintain polio transmission that has not been reached with polio NIDs or mop-up activities.
Benefits of polio eradication Direct benefits
There are clear humanitarian reasons for eradicating polio -the elimination of a major cause of the human suffering, disease and disability. To free humanity forever from the risk of polio represents an enormous humanitarian achievement. Although polio is an increasingly rare disease, as recently as 1990 over 1000 children were permanently paralysed by this virus every day, despite the availability of an excellent vaccine for over 25 years.'.
There are also sound economic arguments. It has been estimated that global polio eradication will achieve direct savings of over £ I billion per year worldwide when polio immunization is stopped", The ultimate cessation of polio prevention measures will thus release already scarce health resources for other purposes. At the community level. eradicating polio will eliminate the costs incurred by the poorest of families in caring for afflicted family members and increase productivity by removing a common disability which prevents people from achieving their full economic potential.
Indirect benefits
In addition to the direct benefits of eradicating polio. there are important 'coincident' or 'consequent' effects on the larger health system in which PEl operates? The major opportunities for such benefits are a result of improvements in health services delivery. particularly for the control of other vaccine-preventable diseases. The PEl has helped to boost the performance of struggling immunization programmes and establish or improve sensitive surveillance systems'', PEl has brought huge investments in cold chain. communications. transport and laboratory equipment across the African and Asian continents in particular. Several countries have seen increased national financing of immunization systems and vaccines and improved community participation and ownership of immunization services''.
As significant as the improvements in immunization service delivery has been the enhanced capacity to evaluate their impact. Global surveillance capacity has been strengthened through training tens of thousands of 1988 350 000 polio cases (estimated) .-
3500* polio cases
health workers worldwide in the basic principles of disease detection. reporting and investigation. Equipment and transport have been provided to resolve logistical impediments to surveillance combined with the development of a communications network for the electronic submission and feedback of surveillance results. Finally. a global network of over 160 laboratories has been established to ensure all countries have access to WHO-accredited enterovirus diagnostic capacity.
Depending on the particular country. PEl has provided other opportunities to improve child health. The most striking example has been the exploitation of NIDs in countries with vitamin A deficiency to also deliver this nutritional supplement thereby helping to reduce all-cause young child mortality. In 1999 alone. it is estimated that over 240000 childhood deaths were averted by including vitamin A in polio NIDslO.
The sustainability of these gains will depend on continued financing for. and political interest in. preventive health services.
Progress toward global polio eradication
Since the WHA established in 1988 the goal to interrupt wild poliovirus transmission worldwide by the end of the year 2000. poliovirus has rapidly disappeared from large areas of the world. Polio cases are now at the lowest point in history having fallen by over 95% worldwide. from an estimated 350000 cases in 1988 to 2320 reported in 2000 (data reported to WHO as of 16 January 2(01).
Wild poliovirus has now been eliminated from three of the five continents that were endemic at the outset of the initiative and the number of polio-infected countries has declined from over 125 in 1988 to at most 25 in 2000 ( Figure I) . Three of the six WHO regions have been free Between 1999 and 2000 alone there was a 60% decline in reported cases, despite a 25% increase in AFP surveillance sensitivity. Much of the progress made during that period was the result of a unanimous WHA resolution in 1999 to 'accelerate' eradication efforts in all remaining endemic countries!'. Subsequently, all polio-endemic countries doubled the number of NIDs rounds conducted each year and began house-to-house vaccine delivery to reach every child.
Despite this progress, it appears that a limited number of countries (up to 20) will still have ongoing transmission after 2000. Four factors contributed to the delay in meeting the original target date:
• lower than expected routine OPV coverage in some large, densely-populated countries • a persistent failure to reach > 85% of children during
NIDs rounds • the late start of activities in some countries (e.g.
Democratic Republic of the Congo, Sierra Leone) • a lack of surveillance leading to late detection of some polio-infected areas.
While the house-to-house approach of the acceleration phase has helped overcome these constraints, the ability of the programme to fully compensate for these problems was compromised by a limited OPV supply in 1999-2000. The eradication programme is now targeting the global interruption of wild poliovirus transmission within 24 months so that global certification could still be achieved, on time, in 2005. Achieving this target will require an even higher quality of eradication activities in the countries with most intense polio transmission. In Asia these are Pakistan, Afghanistan and northern India. In Africa the most intense transmission is occurring in Nigeria, the Democratic Republic of the Congo and Angola", Ethiopia and Bangladesh remain major concerns because of the large population size and recent evidence of ongoing transmission, while eradication efforts continue to be hampered by the effects of conflict in areas such as Somalia, the Sudan and Sierra Leone.
The role of clinicians and district/regional medical officers
The success of the entire Global PEl hinges on rapidly responding to every chain of wild poliovirus transmission. The success of the AFP surveillance strategy to detect endemic or imported wild poliovirus is wholly dependent on the participation and leadership of clinicians and district and regional medical officers.
These physicians, or the health workers under their supervision, are often the first point of contact with formal health services for AFP cases. The rapid investigation of these cases, with the collection of two stool specimens within 48 hours (as per WHO guidelines), is the principle mechanism for identifying polio-infected areas. Ensuring the investigation and collection of specimens from 'non-polio AFP' cases (e.g. cases of suspected Guillain-Barre syndrome) is no less important as this demonstrates the capacity of countries to detect wild poliovirus transmission were it to occur 12 . Even in the absence of wild poliovirus, countries should be detecting and investigating at least one case of AFP per 248 100000 population aged less then 15 years, due to nonpolio causes. To achieve certificaton-standard surveillance countries must also collect two adequate stool specimens within 14 days of the onset of paralysis from 80% of these cases and ensure their processing at a WHO-accredited laboratory. Achieving this standard of performance depends on clinicians and district and regional medical officers.
Conclusion
Polio eradication is 'technically' feasible as there is no non-human reservoir, an effective intervention (OPV), a proven delivery strategy (NIDs) and a sensitive and specific diagnostic tool (viral culture of specimens from AFP cases). The certification of polio eradication in the Americas in 1994 and the Western Pacific in 2000 confirms the operational feasibility of this goal. When the humanitarian, economic and consequent benefits of this initiative are measured against the costs, it is selfevident that polio eradication is not only a 'can do' but a 'must do' for the international community.
Clinicians and district and regional medical officers are central to achieving this international health goal by ensuring the quality of AFP surveillance needed to find the last chains of polio transmission and to certify the world polio-free.
